Morgan Stanley »

Cortexyme shares owned by Morgan Stanley

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-12-31 $144k 77k 1.87
2024-09-30 $6.6k 8.5k 0.78
2024-06-30 $6.4k 8.5k 0.75
2024-03-31 $8.9k 8.4k 1.06
2023-12-31 $9.5k 9.1k 1.05
2023-09-30 $11k 9.5k 1.12
2023-06-30 $11k 7.2k 1.51
2022-12-31 $7.5k 12k 0.64
2022-06-30 $1.2M 535k 2.18
2022-03-31 $5.0M 809k 6.23
2021-06-30 $0 36k 0.00
2020-12-31 $4.5M 162k 27.75
2020-09-30 $621k 13k 49.86
2020-06-30 $668k 14k 46.29
2020-03-31 $470k 10k 45.45
2019-12-31 $5.0M 89k 56.11
2019-09-30 $147k 5.9k 24.69